Insider · CIK 0001250316
David A Scheinberg
Files at SLS (SELLAS Life Sciences Group, Inc.). First filing -, latest -.
In brief
David A Scheinberg files SEC Form 4 as director at SLS (SELLAS Life Sciences Group, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David A Scheinberg has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | SLS SELLAS Life Sciences Group, Inc. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 73,082 | Jan 9, 2026 |
| Jan 22, 2024 | SLS SELLAS Life Sciences Group, Inc. | AGrant or award Common Stock | +6,000 | $0.00 | $0 | 10,582 | Jan 25, 2024 |
| Jan 22, 2024 | SLS SELLAS Life Sciences Group, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Jan 25, 2024 |
Questions about David A Scheinberg
Answered from the filings on this page, as of the latest one.
Is David A Scheinberg buying or selling?
David A Scheinberg has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David A Scheinberg's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David A Scheinberg has 0.
Where does David A Scheinberg file Form 4?
David A Scheinberg has filed Form 4 at SLS (SELLAS Life Sciences Group, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.